If this is your first time here, wed love to meet you and help you discover how great life can be
While efficacy endpoints for weight loss in those trials were modest, the compound exhibited a favorable safety profile, supporting its later GRAS designation for food use
Another investigation involving 7.5 grams of allulose administered before a meal showed trends toward elevated GLP-1 concentrations, but these findings did not consistently reach statistical significance across all measured time points
These risks and uncertainties include, but are not limited to: risks associated with the success, cost and timing of Viking's product candidate development activities and clinical trials, including those for VK2735, VK0214, VK2809, and the company's other incretin and other receptor agonists
Common Side Effects of GLP-1s Many of the side effects listed below can happen to anyone, but some people such as those with underlying gastric motility disorders or gastroparesis can be more at risk for them than others, says Kristin Criner, MD, an endocrinologist and associate professor of clinical medicine at the Lewis Katz School of Medicine at Temple University in Philadelphia
S., Goldstein J